Corn Seed Is 24 Per Cent Volume and 76 Per Cent Price

The global corn seed market is USD 24.60 billion in 2025, reaching USD 35.25 billion by 2033 at a 4.60% compound annual growth rate. Volume over the same period moves from 4.30 million to 4.70 million tonnes — 1.11% a year.

Put the two rates together and the market’s structure falls out of the arithmetic. Volume accounts for 24% of the growth. Price and technology account for 76%. Value per tonne rises from USD 5,721 to USD 7,516, an increase of 31.4% across eight years.

That is the most price-dependent large input market in our agriculture coverage. Crop protection sits at 46% volume and 54% price. Agricultural biologicals inverts it entirely — 68% tonnage, 32% price. Forage and turf is 44/56. Corn is 24/76, and it is the only major category in the cluster where the physical product barely grows at all.

Where the 76% comes from

Not from selling more seed to more land. Maize area is effectively fixed — roughly 209 million hectares across at least 165 countries — and the crop is hybrid on essentially every commercially farmed hectare in the Americas, Europe and China. There is almost no conversion left to model. That is why the defensible number for this market sits below the industry conversation: there is no adoption curve left to draw.

The 76% comes from the price of the bag, and the composition of the price is the single most important fact in the report. Royalty now represents roughly 70% of a United States corn seed bag, against 42% five years earlier. GM-stacked hybrid maize is 50.2% of 2025 market value — and in the GM seed market measured separately, maize is USD 12.34 billion, or 47.2% of GM value, on 75.3 million GM hectares at USD 163.9 a hectare.

A bag that is 70% royalty is not a seed sale. It is a licensing negotiation with a seed attached, and it means the growth rate of this market is a forecast about the value of intellectual property rather than a forecast about agronomy.

The customer is the strangest part of the story

On USDA Economic Research Service data, the average United States corn acre returned a net value of production of minus USD 118.08 after total costs in 2025, with seed accounting for USD 111.33 of the cost of every planted acre. Convert that at 2.471 acres to the hectare and the American grower is paying about USD 275 a hectare for seed against a global average of USD 117 — 2.35 times the world rate.

So the most squeezed customer in world agriculture is paying more per bag than ever, in the same season in which Bayer’s corn seed and traits business grew 13% on an adjusted basis to EUR 7,149 million and Corteva’s corn seed sales rose from USD 6,496 million to USD 7,002 million.

That looks like a market extracting value from a captive customer. It is not. Land, fertiliser and machinery are fixed or sunk by the time planting starts, and the seed is the one line on the field that reliably returns more than it costs. A grower buying a 70%-royalty bag in a loss-making year is behaving rationally, and the reason the 76% has held is that the arithmetic on the field has held.

The three things that could break it

One: a court decision, not a harvest. The 2025 dicamba label vacatur in the United States pulled Bayer’s soybean seed and traits sales down 8% and cotton seed down 23% in a single season, on a judicial ruling rather than a regulator’s determination. Corn carries a heavier trait stack and therefore more of this exposure, not less. When the value of the tolerance trait is a function of the chemistry it tolerates, the chemistry’s legal status is a seed-market variable.

Two: the separation of seed from chemistry. Corteva’s seed and genetics business separated as Vylor on 1 October 2026, and corn is not a division inside Vylor — it is the balance sheet. A pure-play genetics company has no crop protection cash flow to absorb a bad seed season, which argues for firmer pricing and less discounting in a downturn. The 2025 numbers already show the margin gap that motivates the split: Corteva’s seed operating EBITDA was USD 2,636 million on USD 9,898 million of seed sales, a 26.6% margin, against 19.4% for Bayer’s integrated Crop Science division and 15.4% for Syngenta’s group.

Three: China, which is the only place volume can still grow. The 2026 season is the first conducted under ordinary commercial planting rules, with GM maize targeted at 57.85 million mu across 23 provinces plus the Xinjiang Corps and Beidahuang — close to 9% of a national maize seed area of about 650 million mu. Cumulative variety approvals reached 239 by the fourth batch of 2026. China is the only large maize market where the volume line can move, and it is the reason the 24% is not zero.

How to read the forecast

Treat 4.60% as two separate bets that happen to multiply to the same number.

The first bet is that the same hectare keeps absorbing a more expensive genetics package without the grower’s willingness to pay breaking. That has been true for thirty years and it fails when a trait’s value is removed by regulation rather than eroded by competition.

The second bet is that the royalty share of the bag keeps rising, or at least holds. That one is under visible pressure from a different direction: the licensing settlements of 2025 and 2026 have made elite traits purchasable rather than merely licensable, which widens the field of companies selling GM seed and, over time, competes the royalty down rather than up.

The tension between those two — a royalty stack that must hold for the price line, and a licensing market that is deliberately eroding the exclusivity that supports it — is where we would put the risk. Not in the volume line, which is 24% of the answer and the least interesting part of it.

What we would watch: whether triple-stack maize traits reach out-licensing in 2027 as signalled; whether the Chinese area target is met before trait approval becomes the constraint; and whether Vylor’s first full year as a standalone prices firmer than Corteva did inside a chemistry business. The third is the cleanest test of whether the 76% was ever really about agronomy.